scispace - formally typeset
T

Tony J. Kenna

Researcher at Queensland University of Technology

Publications -  73
Citations -  7151

Tony J. Kenna is an academic researcher from Queensland University of Technology. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 29, co-authored 65 publications receiving 6127 citations. Previous affiliations of Tony J. Kenna include University College Dublin & Princess Alexandra Hospital.

Papers
More filters
Journal ArticleDOI

A promoter-level mammalian expression atlas

Alistair R. R. Forrest, +280 more
- 27 Mar 2014 - 
TL;DR: For example, the authors mapped transcription start sites (TSSs) and their usage in human and mouse primary cells, cell lines and tissues to produce a comprehensive overview of mammalian gene expression across the human body.
Journal ArticleDOI

Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

David M. Evans, +92 more
- 01 Aug 2011 - 
TL;DR: In this paper, the identification of three variants in the RUNX3, LTBR-TNFRSF1A and IL12B regions convincingly associated with ankylosing spondylitis (P < 5 x 10(-8) in the combined discovery and replication datasets) and a further four loci at PTGER4, TBKBP1, ANTXR2 and CARD9 that show strong association across all their datasets (p < 5x 10(-6) overall, with support in each of the three datasets studied).
Journal ArticleDOI

In vitro demonstration of the heavy-atom effect for photodynamic therapy.

TL;DR: In vitro light-induced toxicity assays in HeLa cervical carcinoma and MRC5-SV40 transformed fibroblast cancer cell lines confirmed that the heavy-atom effect is viable in a live cellular system and that it can be exploited to modulate assay efficacy.
Journal ArticleDOI

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Adrian Cortes, +68 more
- 09 Jun 2013 - 
TL;DR: In this paper, the authors used the Illumina Immunochip microarray to perform a case-control association study involving 10,619 individuals with ankylosing spondylitis (cases) and 15,145 controls.
Journal ArticleDOI

Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis

TL;DR: In this article, the authors show evidence for a discrete microbial signature in the terminal ileum of patients with ankylosing spondylitis compared with healthy control subjects.